A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

By Gabriel S.E.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

By Lu Ellen   Wang Bing Wei   Guimond Colleen   Synnes Anne   Sadovnick A Dessa   Dahlgren Leanne   Traboulsee Anthony   Tremlett Helen  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Monitoring and Assessing the Safety of Disease-Modifying Antirheumatic Drugs: A West Midlands Experience

By Jobanputra P.   Maggs F.   Homer D.   Bevan J.  

Drug Safety, Vol. 25, Iss. 15, 2002-01 ,pp. : 1099-1105

Adis International

Access to resources Recommend Favorite

Disease-Modifying Antirheumatic Drugs: Using Their Clinical Pharmacological Effects As a Guide to Their Selection

By Jackson C.G.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 337-344

Adis International

Access to resources Recommend Favorite

Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

By Haagsma C.J.  

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 281-289

Adis International

Access to resources Recommend Favorite